Barbara Haber

A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000

Benjamin L. Shneider, Morton B. Brown, Barbara Haber et al. · The Journal of Pediatrics · 2006 · 390 citations

Urology, Biliary Tract, Medicine +5

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

Eric Lawitz, Edward Gane, Brian L. Pearlman et al. · The Lancet · 2014 · 299 citations

Open-label Phase 2, Hepatology, Hepatitis C +10

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

Mark Sulkowski, Christophe Hézode, Jan Gerstoft et al. · The Lancet · 2014 · 279 citations

Open-label Phase 2, Hepatitis C, Viral Hepatitis +8

Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver.

Drew E. Cressman, Linda E. Greenbaum, Barbara Haber et al. · Journal of Biological Chemistry · 1994 · 221 citations · Full text

Rapid Activation, P50/nf-kappa B1, Regenerating Liver +25

Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration.

Barbara Haber, Kenneth Mohn, Robert H. Diamond et al. · Journal of Clinical Investigation · 1993 · 204 citations · Full text

Induction Patterns, Pathology, Growth Period +21